The following tests may be useful in the assessment of a patient with sarcoidosis
**Core Concept**
Sarcoidosis is a systemic granulomatous disease characterized by the accumulation of immune cells, particularly macrophages and lymphocytes, in various organs, including the lungs, skin, and eyes. The diagnosis of sarcoidosis often requires a combination of clinical evaluation, laboratory tests, and imaging studies to establish the presence and extent of the disease.
**Why the Correct Answer is Right**
The assessment of sarcoidosis typically involves a battery of tests to evaluate the extent of the disease and its impact on various organ systems. Among the commonly used tests are:
* Chest radiography to evaluate pulmonary involvement
* Pulmonary function tests (PFTs) to assess lung function and detect signs of respiratory compromise
* Angiotensin-converting enzyme (ACE) levels, which are often elevated in patients with sarcoidosis
* Serum calcium levels, which may be elevated due to vitamin D activation by macrophages in granulomas
* Gallium-67 scan, which can help identify areas of active inflammation
* Computed tomography (CT) scans to evaluate the extent of pulmonary involvement and detect extrapulmonary manifestations
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not a commonly used test in the assessment of sarcoidosis. While some patients with sarcoidosis may develop hypercalcemia, this is not a specific or sensitive marker for the disease.
**Option B:** This option is not typically used in the assessment of sarcoidosis. While some patients may develop skin lesions, the diagnosis of sarcoidosis is not made based on skin biopsy alone.
**Option C:** This option is not a specific or sensitive test for sarcoidosis. While some patients may have elevated levels of lactate dehydrogenase (LDH), this is not a diagnostic marker for the disease.
**Clinical Pearl / High-Yield Fact**
In patients with sarcoidosis, the levels of angiotensin-converting enzyme (ACE) may be elevated, but this is not a specific marker for the disease. A chest radiograph is often the first imaging study performed to evaluate pulmonary involvement, and it may show bilateral hilar lymphadenopathy or pulmonary infiltrates.
**Correct Answer: A. Chest radiography to evaluate pulmonary involvement, pulmonary function tests (PFTs), angiotensin-converting enzyme (ACE) levels, serum calcium levels, gallium-67 scan, and computed tomography (CT) scans.